SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 57 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,789,205 | +1567.5% | 192,094 | +2325.4% | 0.02% | +2000.0% |
| Q1 2023 | $167,270 | -83.4% | 7,920 | -86.3% | 0.00% | -87.5% |
| Q1 2022 | $1,005,000 | +22.1% | 57,804 | +53.7% | 0.01% | 0.0% |
| Q4 2021 | $823,000 | +162.9% | 37,598 | +129.4% | 0.01% | +100.0% |
| Q3 2021 | $313,000 | -13.8% | 16,393 | -22.6% | 0.00% | 0.0% |
| Q2 2021 | $363,000 | -3.2% | 21,166 | +26.4% | 0.00% | -20.0% |
| Q1 2021 | $375,000 | -51.0% | 16,751 | -51.4% | 0.01% | -54.5% |
| Q4 2020 | $766,000 | +571.9% | 34,447 | +347.4% | 0.01% | +450.0% |
| Q3 2020 | $114,000 | -50.2% | 7,700 | -50.2% | 0.00% | -50.0% |
| Q2 2020 | $229,000 | +1247.1% | 15,461 | +621.1% | 0.00% | +300.0% |
| Q3 2018 | $17,000 | +6.2% | 2,144 | +78.7% | 0.00% | 0.0% |
| Q1 2017 | $16,000 | -15.8% | 1,200 | -55.0% | 0.00% | -50.0% |
| Q4 2016 | $19,000 | – | 2,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |